Shukra Pharmaceuticals Receives MCA Approval for Name Change to Shukra Medtech
Shukra Pharmaceuticals Ltd 路 Others (Uncategorized) 路 13 Oct 2026, 12:34 am
Shukra Pharmaceuticals Receives MCA Approval for Name Change to Shukra Medtech The Ministry of Corporate Affairs approved the name change of Shukra Pharmaceuticals Limited to Shukra Medtech Limited, effective 12th Oct'26, following the issuance of a fresh Certificate of Incorporation. The rebranding is driven by business restructuring and alignment with the company鈥檚 future corporate strategy focused on technology-driven healthcare operations. The company is completing formalities with stock exchanges to update records and transition to a new trading symbol.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
